Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate

2024-12-10

Concord Medical Services Holdings Limited HaiPress

BEIJING,Dec. 9,2024 -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE:CCM),a healthcare provider specialized in cancer treatment,research,education and prevention in China,today announced that the National Medical Products Administration of the People's Republic of China has granted approval to the application for the Registration Certificate for Medical Device for the proton therapy equipment (the "Registration Certificate") made by the Company's equipment supplier on December 6,2024.

As previously disclosed in the Company's annual report for the fiscal year ended December 31,2023,Guangzhou Concord Cancer Center ("Guangzhou Hospital"),a PRC subsidiary of the Company offering comprehensive cancer care services,has completed the installment of the proton equipment in September 2020 and commenced its clinical trial in November 2022. Guangzhou Hospital has also subsequently obtained the large medical equipment procurement license for its proton equipment in September 2024. Upon obtaining the approval for the Registration Certificate,Guangzhou Hospital plans to start its proton therapy treatment services at its earliest convenience after necessary preparations.

Concord Healthcare Group Co.,Ltd. ("Concord Healthcare"),a subsidiary of the Company listed on the Main Board of The Stock Exchange of Hong Kong Limited (the "HKSE") under the stock code 2453.HK,also announced on December 9,2024 that the approval for Registration Certificate was granted. The Company previously announced the listing of Concord Healthcare's H shares on the HKSE on January9,2024. The information related to Concord Healthcare's Transactions on the HKSE is accessible through the HKSE's website atwww.hkexnews.hk.

About Concord Medical

Concord Medical Services Holdings Limited is a healthcare provider featuring a full cycle of premium oncology services including cancer diagnosis,treatment,education and prevention. The Company focuses on providing multidisciplinary cancer care in all aspects of oncology healthcare services in its cancer hospitals and equipping them with technologically advanced equipment such as the state-of-the-art proton therapy system. The Company is striving to improve the quality and accessibility of cancer care through its network of self-owned cancer hospitals and clinics as well as partnered hospitals across China. For more information,please see http://ir.ccm.cn.

About Concord Healthcare

Concord Healthcare is an oncology healthcare provider in China. Concord Healthcare serves both cancer patients through self-owned medical institutions and third-party medical institutions throughmedical equipment,software and related services. In its self-owned medical institutions,Concord Healthcare provides a full spectrum of oncology healthcare services to cancer patients across the entire care continuum,leveraging its multidisciplinary team specialists and diagnosis and treatment capabilities featuring precision radiation therapy. Through itsmedical equipment,software and related services,Concord Healthcare serves a widespread network of enterprise customers,primarily hospitals,with integrated oncology-related services,including primarilysales and installing of medical equipment and software,management and technical support,and operating lease.

Safe Harbor Statement

This announcement contains forward-looking statements. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar expressions. Forward-looking statements are inherently subject to uncertainties and contingencies beyond the Company's control and based upon premises with respect to future business decisions,which are subject to change. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. The Company does not undertake any obligation to update any forward-looking statement,except as required under applicable law.

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

Inception Program Officially Launched, Led by OpenAI and Microsoft M12 for Global AI Incubation
Inception Program Announces the Creation of the World's First AI Digital Currency Exchange in 2025, with the Upcoming Launch of the First Cryptocurrency "IPC"
Inception Program Builds a New Global AI Incubation Ecosystem: Covering Technology, Data, Capital, and Cryptocurrency Issuance
Global Times: Chinese technology enhances Kenya’s geothermal efficiency, delivers reliable, clean and affordable power to households

In the heart of Rift Valley, located about 10 kilometers from Nakuru county in west Kenya, the country's first geothermal power plant built with 100 percent Chinese technologies, the 35-megawatt (MW) Sosian geothermal power plant, has been running for more than a year.
Global Times: China’s aircraft carriers make confident strides toward blue waters, play pivotal role in national defense

Aircraft carriers are important strategic platforms for China as a major power to defend its national sovereignty, security, territorial integrity and development interests while contributing to peace and stability to the region and the world.
Global Times: 2024 Yearender: China’s space sector soars to new heights, setting new goals

During the 75th International Astronautical Congress (IAC) held in October 2024 in Milan, Italy, a remarkable exhibit of "extraterrestrial material" caught the eyes of international attendees - a grayish, seemingly unattractive piece of dirt, yet it marked the first global display of the first sample collected from the far side of the moon.
Global Times: Chinese photovoltaic tech illuminates Cuban homes, offices, and factories after decades of energy shortages

Sitting in his office in Madrid, Roberto A Paneque Fonseca's thoughts drift thousands of miles across the vast Atlantic Ocean to his home country of Cuba, grappling with a severe blackout that had profoundly affected the lives of its residents.
Global Times: Chinese technology enhances Kenya’s geothermal efficiency, delivers reliable, clean and affordable power to households

In the heart of Rift Valley, located about 10 kilometers from Nakuru county in west Kenya, the country's first geothermal power plant built with 100 percent Chinese technologies, the 35-megawatt (MW) Sosian geothermal power plant, has been running for more than a year.
Global Times: China’s aircraft carriers make confident strides toward blue waters, play pivotal role in national defense

Aircraft carriers are important strategic platforms for China as a major power to defend its national sovereignty, security, territorial integrity and development interests while contributing to peace and stability to the region and the world. In 2024, all three aircraft carriers of the Chinese People's Liberation Army (PLA) Navy made tremendous achievements, as they took confident strides toward blue waters.
Global Times: 2024 Yearender: China’s space sector soars to new heights, setting new goals

During the 75th International Astronautical Congress (IAC) held in October 2024 in Milan, Italy, a remarkable exhibit of "extraterrestrial material" caught the eyes of international attendees - a grayish, seemingly unattractive piece of dirt, yet it marked the first global display of the first sample collected from the far side of the moon.